February 4th, 2015
Jehad Al Buraiki and Joseph G. Akar offer differing perspectives, from each side of the Atlantic, on cardiac resynchronization-pacemaker therapy.
September 11th, 2014
Boback Ziaeian discusses his observational study exploring the benefits of guideline-recommended cardiac resynchronization therapy and ICD therapy in heart failure patients, according to race and ethnicity.
April 7th, 2014
This week’s topics include SYMPLICITY HTN-3, CoreValve, MADIT-CRT, and more.
March 30th, 2014
Arthur J. Moss discusses his research group’s study of long-term survival for patients who received cardiac resynchronization therapy with a defibrillator in the MADIT-CRT trial.
March 3rd, 2014
Anna Catino presents our latest case: A young, male, long-distance runner experiencing palpitations, who has lamin A/C deficiency and a family history of cardiac disease. How would you manage this patient?
October 14th, 2013
This week’s topics include CRT in HF with a narrow QRS complex, a trial of edoxaban vs. warfarin for symptomatic VTE, and more.
September 19th, 2013
Sergio Richter discusses his research group’s study of a non–fluoroscopy-based tracking system that can be used when implanting a CRT device.
September 3rd, 2013
Clyde Yancy, coauthor of the NEJM editorial about the EchoCRT Study Group’s randomized trial of echocardiography-guided CRT, provides further insights about the findings.
August 13th, 2013
A large observational study published in JAMA suggests that patients with left bundle-branch block (LBBB) and longer QRS duration derive the most benefit from a cardiac resynchronization therapy defibrillator (CRT-D). The findings appear to support current, but often criticized, guidelines from the American College of Cardiology, American Heart Association, and the Heart Rhythm Society, in which a class I […]
April 26th, 2013
Two new trials have ended up reporting conflicting results regarding the expansion of the indication for cardiac resynchronization therapy (CRT) for patients without a wide QRS interval. The positive results of the smaller trial seem likely to be undermined by the early stopping of the much larger trial. The first trial, NARROW-CRT, published in Circulation: Arrhythmia […]